NIH-funded research NIH-funded research

Understanding how a protein affects attention and alertness in brain disorders

Official title: Vulnerability of the ascending arousal network to alpha-synuclein pathology

Funded at University of Iowa · NIH-10979569 · Data updated 2026-11-12

This study is looking at how changes in thinking and attention happen in people with Lewy body disorders, like Parkinson's Disease dementia, by testing how a protein called alpha-synuclein affects the brain in animal models, with the hope of finding better treatments for those who experience these challenges.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startSeptember 18, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$2,234,905
NIH project number1RF1NS134833-01A1
Project IDNIH-10979569 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Lewy body disorders, including Parkinson's Disease dementia and Dementia with Lewy Bodies.

Less likely to help

Patients with cognitive fluctuations not related to Lewy body disorders may not benefit from this research.

What this research studies

This research investigates the cognitive fluctuations experienced by patients with Lewy body disorders, which include conditions like Parkinson's Disease dementia and Dementia with Lewy Bodies. By using animal models, the study aims to explore how the protein alpha-synuclein affects brain circuits responsible for attention and arousal. The researchers will inject this protein into specific areas of the brain to observe its impact on cognitive functions. The ultimate goal is to uncover the mechanisms behind these fluctuations to develop targeted treatments for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cognitive stability and independence for patients with Lewy body disorders.

How similar studies have gone: While the specific approach of this research is novel, similar studies have shown promise in understanding the effects of alpha-synuclein in related conditions.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Aldridge, Georgina — University of Iowa
  • Study coordinator: Aldridge, Georgina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.